Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $16.7900 (-0.83%) ($16.6500 - $17.1700) on Thu. Nov. 2, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.15% (three month average) | RSI | 42 | Latest Price | $16.7900(-0.83%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.2% a day on average for past five trading days. | Weekly Trend | HALO declines -1.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(56%) IWO(55%) XBI(53%) IWM(50%) ARKG(49%) | Factors Impacting HALO price | HALO will decline at least -1.575% in a week (0% probabilities). VIXM(-13%) UUP(-11%) TLT(-6%) SHY(-3%) IGOV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.575% (StdDev 3.15%) | Hourly BBV | 0 () | Intraday Trend | -1% | | | |
|
Resistance Level | $17.36 | 5 Day Moving Average | $17.25(-2.67%) | 10 Day Moving Average | $17.28(-2.84%) | 20 Day Moving Average | $17.36(-3.28%) | To recent high | -6% | To recent low | 42.8% | Market Cap | $2.295b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |